+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

Influence of Saccharomyces boulardii Sachets combined with bismuth quadruple therapy for initial Helicobacter pylori eradication

Influence of Saccharomyces boulardii Sachets combined with bismuth quadruple therapy for initial Helicobacter pylori eradication

Zhonghua Yi Xue Za Zhi 97(30): 2353-2356

ISSN/ISBN: 0376-2491

PMID: 28822453

目的: 评价布拉氏酵母菌散联合含铋剂四联疗法根除幽门螺杆菌(H.pylori)的有效性和安全性。 方法: 选取2014年3月至2015年3月于河北医科大学附属第三医院就诊的H.pylori阳性患者240例,按随机数字表法随机分为3组。四联组:枸橼酸铋钾220 mg+雷贝拉唑钠肠溶片10 mg+阿莫西林1 000 mg+呋喃唑酮100 mg,2次/d口服,共10 d;短疗程益生菌组:在上述四联组基础上,自服药第1天始口服布拉氏酵母菌散500 mg,2次/d,共14 d;长疗程益生菌组:在四联组基础上,自服药第1天始口服布拉氏酵母菌散500 mg,2次/d,共28 d;所有用药停药至少4周后行(13)C尿素呼气试验((13)C-UBT)或(14)C-UBT,结果阴性者视为H.pylori根除成功,观察并记录治疗过程中的不良反应。 结果: 四联组、短疗程益生菌组和长疗程益生菌组意向性(ITT)分析的根除率分别为80.0%(64/80)、87.5%(70/80)、87.5%(70/80),差异无统计学意义(P=0.321);3组符合方案(PP)分析的根除率分别为92.8%(64/69)、94.6%(70/74)、95.9%(70/73) ,差异无统计学意义(P=0.717);短疗程益生菌组不良反应的总体发生率以及腹泻、腹胀的发生率均低于四联组,差异有统计学意义(P=0.007、0.003、0.004),长疗程益生菌组不良反应的总体发生率以及腹泻、腹胀的发生率均低于四联组,差异有统计学意义(P=0.005、0.001、0.010),而两益生菌组不良反应发生率比较差异无统计学意义。 结论: 2周或4周布拉氏酵母菌散加入含铋剂四联根除H.pylori方案,均可降低不良反应的总体发生率和腹泻、腹胀的发生率。.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 059858961

Download citation: RISBibTeXText

Related references

Influence of different timing of Saccharomyces boulardii combined with bismuth quadruple therapy for Helicobacter pylori eradication. Zhonghua Yi Xue Za Zhi 99(22): 1731-1734, 2019

Influence of two kinds of probiotics combined with bismuth quadruple therapy for Helicobacter pylori eradication. Zhonghua Yi Xue Za Zhi 98(28): 2246-2249, 2018

Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy. Gastroenterologia y Hepatologia 43(6): 301-309, 2020

High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. Helicobacter 15(3): 233-238, 2010

Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen. Medical Principles and Practice: International Journal of the Kuwait University Health Science Centre 26(6): 523-529, 2017

A meta-analysis of randomized controlled trials of bismuth-containing quadruple therapy combined with probiotic supplement for eradication of Helicobacter pylori. Zhonghua Nei Ke Za Zhi 56(10): 752-759, 2017

Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori. Canadian Journal of Gastroenterology 15(9): 581-585, 2001

Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice?. Gastroenterology 152(1): 301-302, 2017

Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial. World Journal of Gastroenterology 25(46): 6743-6751, 2019

Bismuth-based quadruple therapy with colloidal bismuth subcitrate + tetracycline + metronidazole + omeprazole in eradication of M sensitive and M resistant Helicobacter pylori. Gastroenterology 116(4 Part 2): A227, 1999

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori. Clinical and Experimental Gastroenterology 5: 23-34, 2012

Helicobacter pylori eradication: A new, single-capsule bismuth-containing quadruple therapy. Nature Reviews. Gastroenterology and Hepatology 8(6): 307-309, 2011

Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradication. Helicobacter 2(3): 140-143, 1997

Evaluation of different proton pump inhibitors combined with bismuth quadruple regimens in Helicobacter pylori eradication. Clinical and Experimental Medicine 20(4): 609-614, 2020

Amoxicillin-Clarithromycin-Containing Bismuth Quadruple Therapy for Primary Eradication of Helicobacter pylori. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 41(1): 75-79, 2019